{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:16Z","timestamp":1792788016815,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010814","name":"Anhui Provincial Department of Education","doi-asserted-by":"publisher","award":["2024AH050693"],"award-info":[{"award-number":["2024AH050693"]}],"id":[{"id":"10.13039\/501100010814","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Natural Science Foundation of China","award":["11671375"],"award-info":[{"award-number":["11671375"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"DOI":"10.1186\/s12911-026-03671-2","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:16:11Z","timestamp":1782803771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multitask learning of longitudinal circulating biomarkers and clinical outcomes: identification of optimal machine-learning and deep-learning models"],"prefix":"10.1186","volume":"26","author":[{"given":"Min","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu Steven","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"9","key":"3671_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrg.2016.86","volume":"17","author":"EA Ashley","year":"2016","unstructured":"Ashley EA. Towards precision medicine. Nat Rev Genet. 2016;17(9):507\u201322.","journal-title":"Nat Rev Genet"},{"key":"3671_CR2","doi-asserted-by":"crossref","unstructured":"Moons KGM, et al. Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ. 2009;338.","DOI":"10.1136\/bmj.b606"},{"key":"3671_CR3","first-page":"711","volume-title":"A Tumor Growth Inhibition Model Based on M-Protein Levels in Subjects With Relapsed\/Refractory Multiple Myeloma Following Single-Agent Carfilzomib Use","author":"F Jonsson","year":"2015","unstructured":"Jonsson F, et al. A Tumor Growth Inhibition Model Based on M-Protein Levels in Subjects With Relapsed\/Refractory Multiple Myeloma Following Single-Agent Carfilzomib Use. Volume 4. CPT: pharmacometrics & systems pharmacology; 2015. pp. 711\u20139. 12."},{"issue":"17","key":"3671_CR4","doi-asserted-by":"publisher","first-page":"5342","DOI":"10.1158\/1078-0432.CCR-18-3335","volume":"25","author":"O Colomban","year":"2019","unstructured":"Colomban O, et al. Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study. Clin Cancer Res. 2019;25(17):5342\u201350.","journal-title":"Clin Cancer Res"},{"key":"3671_CR5","doi-asserted-by":"crossref","unstructured":"Yang CY, et al. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes. Cardiovasc Diabetol. 2020;19(1).","DOI":"10.1186\/s12933-020-01082-9"},{"key":"3671_CR6","doi-asserted-by":"crossref","unstructured":"Bruno R, et al. Support to early clinical decisions in drug development and personalised medicine with checkpoint inhibitors using dynamic biomarker-overall survival models. Br. J. Cancer. 2023.","DOI":"10.1038\/s41416-023-02190-5"},{"key":"3671_CR7","doi-asserted-by":"crossref","unstructured":"Kim HU, Park SP, Kim YK. Long-term HbA1c variability and the development and progression of diabetic retinopathy in subjects with type 2 diabetes. Sci Rep. 2021;11(1).","DOI":"10.1038\/s41598-021-84150-8"},{"key":"3671_CR8","doi-asserted-by":"crossref","unstructured":"Netterberg I, et al. A PK\/PD Analysis of circulating biomarkers and their relationship to tumor response in atezolizumab-treated non-small cell lung cancer patients. Clin Pharmacol Ther. 2019;105(2):486\u201395.","DOI":"10.1002\/cpt.1198"},{"key":"3671_CR9","doi-asserted-by":"crossref","unstructured":"Jin C, et al. Predicting treatment response from longitudinal images using multi-task deep learning. Nat Commun. 2021;12(1).","DOI":"10.1038\/s41467-021-22188-y"},{"key":"3671_CR10","doi-asserted-by":"crossref","unstructured":"Li FL, et al. Deep learning-based predictive biomarker of pathological complete response to neoadjuvant chemotherapy from histological images in breast cancer. J Transl Med. 2021;19:1.","DOI":"10.1186\/s12967-021-03020-z"},{"key":"3671_CR11","doi-asserted-by":"crossref","unstructured":"Gavrilov S, et al. Longitudinal tumor size and neutrophil-to-lymphocyte ratio are prognostic biomarkers for overall survival in patients with advanced non-small cell lung cancer treated with durvalumab. CPT Pharmacometrics Syst. Pharmacol. 2021;10(1)67\u201374.","DOI":"10.1002\/psp4.12578"},{"issue":"2","key":"3671_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1161\/CIRCULATIONAHA.121.057480","volume":"145","author":"S Khurshid","year":"2022","unstructured":"Khurshid S, et al. ECG-Based Deep Learning and Clinical Risk Factors to Predict Atrial Fibrillation. Circulation. 2022;145(2):122\u201333.","journal-title":"Circulation"},{"key":"3671_CR13","doi-asserted-by":"crossref","unstructured":"van Delft FA, et al. Modeling strategies to analyse longitudinal biomarker data: an illustration on predicting immunotherapy non-response in non-small cell lung cancer. HELIYON. 2022;8(10).","DOI":"10.1016\/j.heliyon.2022.e10932"},{"issue":"7","key":"3671_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1470-2045(15)00021-2","volume":"16","author":"N Thatcher","year":"2015","unstructured":"Thatcher N, et al. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial. LANCET Oncol. 2015;16(7):763\u201374.","journal-title":"LANCET Oncol"},{"issue":"4","key":"3671_CR15","doi-asserted-by":"publisher","first-page":"863","DOI":"10.2307\/2529811","volume":"31","author":"CC Brown","year":"1975","unstructured":"Brown CC. USE OF INDICATOR VARIABLES FOR STUDYING TIME-DEPENDENCE OF PARAMETERS IN A RESPONSE-TIME MODEL. Biometrics. 1975;31(4):863\u201372.","journal-title":"Biometrics"},{"key":"3671_CR16","unstructured":"Kvamme H, Borgan O, Scheel I. Time-to-event prediction with neural networks and cox regression. J Mach Learn Res. 2019;20."},{"key":"3671_CR17","doi-asserted-by":"crossref","unstructured":"Lee C, et al. DeepHit: a deep learning approach to survival analysis with competing risks, In thirty-second AAAI conference on artificial intelligence \/ thirtieth innovative applications of artificial intelligence conference \/ eighth AAAI symposium on educational advances in artificial intelligence. 2018;2314\u20132321.","DOI":"10.1609\/aaai.v32i1.11842"},{"issue":"4","key":"3671_CR18","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s10985-021-09532-6","volume":"27","author":"H Kvamme","year":"2021","unstructured":"Kvamme H, Borgan O. Continuous and discrete-time survival prediction with neural networks. Lifetime Data Anal. 2021;27(4):710\u201336.","journal-title":"Lifetime Data Anal"},{"key":"3671_CR19","doi-asserted-by":"crossref","unstructured":"Katzman JL, et al. DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network. BMC Med Res Methodol. 2018;18.","DOI":"10.1186\/s12874-018-0482-1"},{"key":"3671_CR20","doi-asserted-by":"crossref","unstructured":"Jarrett D, Yoon J, van der Schaar M. Dynamic prediction in clinical survival analysis using temporal convolutional networks. IEEE J Biomed Health Inform. 2020;24(2)424\u201336.","DOI":"10.1109\/JBHI.2019.2929264"},{"key":"3671_CR21","doi-asserted-by":"crossref","unstructured":"Lin J, Luo S. Deep learning for the dynamic prediction of multivariate longitudinal and survival data. Stat Med. 2022;41(15)2894\u2013907.","DOI":"10.1002\/sim.9392"},{"key":"3671_CR22","doi-asserted-by":"crossref","unstructured":"Happ C, Greven S. Alzheimer\u2019s dis neuroimaging, multivariate functional principal component analysis for data observed on different (dimensional) domains. J Am Stat Assoc. 2018;113(522)649\u201359.","DOI":"10.1080\/01621459.2016.1273115"},{"issue":"4","key":"3671_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0031-3203(73)90025-3","volume":"5","author":"J Kittler","year":"1973","unstructured":"Kittler J, Young PC. NEW APPROACH TO FEATURE SELECTION BASED ON KARHUNEN-LOEVE EXPANSION. Pattern Recogn. 1973;5(4):335\u201352.","journal-title":"Pattern Recogn"},{"issue":"8","key":"3671_CR24","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jclinepi.2009.11.009","volume":"63","author":"K Rufibach","year":"2010","unstructured":"Rufibach K. Use of Brier score to assess binary predictions. J Clin Epidemiol. 2010;63(8):938\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"24","key":"3671_CR25","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1200\/JCO.2006.06.4246","volume":"24","author":"M Hussain","year":"2006","unstructured":"Hussain M, et al. Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162). J Clin Oncol. 2006;24(24):3984\u201390.","journal-title":"J Clin Oncol"},{"key":"3671_CR26","doi-asserted-by":"crossref","unstructured":"de Crevoisier R, et al. Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy. Ann Oncol. 2010;21(4)808\u201314.","DOI":"10.1093\/annonc\/mdp365"},{"key":"3671_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejca.2016.03.070","volume":"61","author":"A Fuerea","year":"2016","unstructured":"Fuerea A, et al. Early PSA response is an independent prognostic factor in patients with metastatic castration-resistant prostate cancer treated with next-generation androgen pathway inhibitors. Eur J Cancer. 2016;61:44\u201351.","journal-title":"Eur J Cancer"},{"issue":"4","key":"3671_CR28","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.eururo.2019.11.021","volume":"77","author":"N Matsubara","year":"2020","unstructured":"Matsubara N, et al. Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen Deprivation Therapy: Post Hoc Analysis of Phase 3 LATITUDE Study. Eur Urol. 2020;77(4):494\u2013500.","journal-title":"Eur Urol"},{"key":"3671_CR29","doi-asserted-by":"crossref","unstructured":"Hickey GL, et al. Joint modelling of time-to-event and multivariate longitudinal outcomes: recent developments and issues. BMC Med Res Methodol. 2016;16.","DOI":"10.1186\/s12874-016-0212-5"},{"key":"3671_CR30","unstructured":"Vaswani A, et al. Attention is all you need. Adv Neural Inf Process Syst. 2017;30 (NIPS 2017)."},{"key":"3671_CR31","doi-asserted-by":"crossref","unstructured":"Yao F, Muller HG, Wang JL. Functional data analysis for sparse longitudinal data. J Am Stat Assoc. 2005;100(470)577\u201390.","DOI":"10.1198\/016214504000001745"},{"key":"3671_CR32","doi-asserted-by":"crossref","unstructured":"Cai TT, Yuan M. Minimax and adaptive prediction for functional linear regression. J Am Stat Assoc. 2012;107(499):1201\u201316.","DOI":"10.1080\/01621459.2012.716337"},{"key":"3671_CR33","doi-asserted-by":"crossref","unstructured":"Van Houwelingen H. and Hein Putter. Dynamic prediction in clinical survival analysis. 2011;CRC Press.","DOI":"10.1201\/b11311"},{"issue":"6","key":"3671_CR34","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/bimj.201600238","volume":"59","author":"D Rizopoulos","year":"2017","unstructured":"Rizopoulos D, Molenberghs G, Lesaffre E. Dynamic predictions with time-dependent covariates in survival analysis using joint modeling and landmarking. Biom J. 2017;59(6):1261\u201376.","journal-title":"Biom J"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-026-03671-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-026-03671-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-026-03671-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:04:10Z","timestamp":1789650250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12911-026-03671-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3671"],"URL":"https:\/\/doi.org\/10.1186\/s12911-026-03671-2","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"23 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original clinical trial protocol obtained ethical approval from the review boards at each of the participating sites, adhering strictly to the principals outlined in the Declaration of Helsinki and Good Clinical Practice guidelines. Before enrolling in the study, all patients provided written informed consent, demonstrating their voluntary and well-informed decision to participate in the research. The trial was registered on\n                      \n                      under the unique identifier NCT00981058. Data used in current study was downloaded from Datasphere which is the leading oncology open access data sharing platform with de-identified patient-level data contributed by industry, academia, and PDS research programs. Therefore, the current study was exempted from Institutional Review Board review because it included secondary analysis of de-identified data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Authors\u2019 information","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"355"}}